LLY — Eli Lilly and Co Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareBalancedLarge CapHigh Flyer

Annual balance sheet for Eli Lilly and Co, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	3,681	3,909	2,212	2,928	3,423
Net Total Accounts Receivable
Net Total Receivables	6,929	8,127	8,559	11,336	13,275
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	17,462	18,452	18,035	25,727	32,740
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	8,682	8,985	10,144	12,914	17,102
Net Goodwill
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	46,633	48,806	49,490	64,006	78,715
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	12,482	15,053	17,138	27,293	28,377
Long Term Debt
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Funded Status
Total Liabilities	40,992	39,827	38,840	53,234	64,523
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Unrealized Gain / Loss
Other Equity
Total Equity	5,642	8,979	10,650	10,772	14,192
Total Liabilities & Shareholders' Equity	46,633	48,806	49,490	64,006	78,715
Total Common Shares Outstanding